Pharmaceutical Composition for Hoarseness Relief
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for hoarseness and inflammatory diseases of the mouth and throat, such as sore throats, often fail to provide satisfactory relief from pain and inflammatory symptoms, especially for organic causes, and existing remedies like hot milk with honey can exacerbate issues or offer only short-term relief.
Innovation Solution
A pharmaceutical composition combining antiviral polysaccharides, polyhexanide as a surface disinfectant, and hyaluronic acid, which forms a protective film on the mucous membrane to prevent pathogen penetration, reduce dryness, and provide long-lasting pain relief.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If home remedies like hot milk with honey are used, then temporary soothing effect is achieved, but mucus formation increases and healing process is hindered
Solution Approach 1:
The patent converts the harmful effect of honey (increasing mucus formation) into a beneficial formulation by combining it with specific antiviral polysaccharides and polyhexanide. The composition maintains the soothing property while the polysaccharides counteract the mucus-forming effect, transforming a harmful home remedy into an effective pharmaceutical composition.
Solution Approach 2:
The invention creates a composite pharmaceutical composition combining multiple active ingredients: antiviral polysaccharides (from plants or fungi), polyhexanide (surface disinfectant), and optionally local anesthetics or anti-inflammatory agents. This composite formulation achieves both soothing and antimicrobial effects simultaneously, resolving the contradiction between temporary relief and harmful mucus formation.
2Ease of operation
If commercially available lozenges are used, then short-term relief is provided, but effect wears off extremely quickly
Solution Approach 1:
The patent ensures continuous therapeutic action by formulating a composition with slow-release properties. The polysaccharide matrix and polyhexanide combination provides sustained release of antiviral and anti-inflammatory active ingredients, maintaining effective concentrations in the throat area for extended periods rather than the brief duration of conventional lozenges.
Solution Approach 2:
The invention changes the release parameters of the active ingredients by using polysaccharide-based matrices that control diffusion and degradation rates. This parameter modification extends the duration of action from minutes to hours, allowing the composition to maintain therapeutic effectiveness throughout the day.
3Ease of operation
If conventional treatments are used for inflammatory diseases, then some symptom relief is achieved, but sufficient relief from pain and inflammatory symptoms is not provided
Solution Approach 1:
The patent merges multiple therapeutic mechanisms into a single composition: antiviral polysaccharides provide direct viral inhibition and immunomodulation, polyhexanide provides broad-spectrum antimicrobial activity, and optional local anesthetics/anti-inflammatories provide immediate symptom relief. This combination achieves reliable and sufficient relief from pain and inflammatory symptoms that conventional single-mechanism treatments cannot provide.
Solution Approach 2:
The composition is designed for local application in the throat and mouth areas, with formulations specifically tailored to provide high concentrations of active ingredients at the site of infection. The local anesthetics and anti-inflammatories are positioned to act directly on inflamed tissues, providing reliable pain and inflammation relief in the specific affected areas.
4Reliability
If antiviral polysaccharides and polyhexanide are combined, then synergistic effect is achieved, but formulation complexity increases
Solution Approach 1:
The patent uses polysaccharides as intermediary substances that facilitate the interaction between polyhexanide and the target pathogens. The polysaccharide matrix enhances the antimicrobial activity of polyhexanide through synergistic mechanisms, while the combination is formulated in a way that maintains stability and compatibility, managing the formulation complexity through careful selection of excipients and processing methods.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition achieves excellent and sustained relief from hoarseness, pain, and inflammatory symptoms, with a synergistic effect that surpasses the individual contributions of its components, offering rapid and long-lasting benefits while being well-tolerated for extended use.
Implementation Method 1
The composition - in combination and in each case effective, in particular pharmaceutically effective amounts - (a) at least one virustatic or antiviral polysaccharide, selected from carrageenans and/or their physiologically tolerated salts, galactan sulfates and/or their physiologically tolerated salts and polyuronides and/or their physiologically tolerated salts
Implementation Method 2
hyaluronic acid or its salts ('component (c)')
Implementation Method 3
Polyhexanide as a surface disinfectant, ('Component (b)')
Data Source
AI summary
The invention relates to a pharmaceutical composition, which is present preferably in the form of a solid dosage form, for the topical treatment of hoarseness or sore throat and/or inflammatory diseases of the mouth and pharynx. The composition contains in pharmaceutically effective amounts: (a) at least one polysaccharide, preferably a virustatic and/or antiviral polysaccharide, (b) at least one surface disinfectant, and (c) optionally at least one preferably acidic glycosaminoglycan or the physiologically acceptable salts or derivatives thereof, in particular hyaluronic acid or its salts.